Portugal

The paradox of innovation in Portugal: private investment does not accompany public support

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/09/2026, 05:56:24 UTC.

Briefings

Portugal ranks 15th in the European Innovation Scoreboard 2026 with a 93.2% performance, yet private investment in innovation remains significantly below the EU average. The core issue is the lack of 'additional private investment' following public funding, where public money often fails to convert into commercial outcomes due to a 'valley of death' between research and market. The new AI2 agency and revised science law aim to distinguish between fundamental research (focusing on scientific excellence) and applied research (focusing on commercial impact and additional private investment).

Key points

• Portugal ranks 15th among EU member states in the European Innovation Scoreboard 2026 with a performance of 93.2%, representing a 13-point improvement since 2019.
• The new AI2 agency and revised science law are designed to distinguish between fundamental research (focusing on scientific excellence) and applied research (focusing on commercial impact and additional private investment).

Context and limitations

Evidence covers the 2026 European Innovation Scoreboard ranking and the strategic shift under AI2 and the new science law. Data on specific investment amounts, spin-off survival rates, or export values is not provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 29/09/2026, 05:58:26 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeihxs5so4443ipsyktkscjffss62bblugss3lnix3cca4i7xaixiee